Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Depreciation & Amortization (CF): 2022-2025

Historic Depreciation & Amortization (CF) for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to $113,360.

  • bioAffinity Technologies' Depreciation & Amortization (CF) fell 25.08% to $113,360 in Q3 2025 from the same period last year, while for Sep 2025 it was $534,809, marking a year-over-year decrease of 10.98%. This contributed to the annual value of $605,637 for FY2024, which is 142.65% up from last year.
  • bioAffinity Technologies' Depreciation & Amortization (CF) amounted to $113,360 in Q3 2025, which was up 0.12% from $113,229 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Depreciation & Amortization (CF) peaked at $154,588 during Q1 2025, and registered a low of $773 during Q3 2022.
  • Over the past 3 years, bioAffinity Technologies' median Depreciation & Amortization (CF) value was $148,787 (recorded in 2023), while the average stood at $112,401.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 7,347.48% in 2023, then dropped by 25.08% in 2025.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Depreciation & Amortization (CF) stood at $7,330 in 2022, then surged by 1,929.84% to $148,787 in 2023, then climbed by 3.26% to $153,632 in 2024, then declined by 25.08% to $113,360 in 2025.
  • Its Depreciation & Amortization (CF) was $113,360 in Q3 2025, compared to $113,229 in Q2 2025 and $154,588 in Q1 2025.